Company: 
About
Mr. Wagner, age 55, is Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals, Inc., a role he has served in since 2019. In this role, he oversees a range of functions for Vertex including accounting, finance, internal audit, investor relations, business development, and global security and facilities functions. Prior to joining Vertex, from 2015 until 2019, Mr. Wagner was Executive Vice President, Finance and CFO at Ortho Clinical Diagnostics, which he joined after serving in several senior financial roles in the life sciences and other industries. Mr. Wagner has a long history of corporate finance experience, including more than a decade in public and private company CFO roles. This extensive experience has provided him with enterprise-wide expertise, including a deep knowledge of corporate finance and accounting, business strategy, investor relations, and global operations.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
| Company | Committee | Position | Date Appointed |
|---|---|---|---|
![]() | Board | Chief Financial Officer | 01/01/2019 |
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Marshalls | Board | Member | 01/01/2023 | |
| Marshalls | Audit | Member | 01/01/2023 | |
| TJX | Board | Member | 01/01/2023 | |
| TJX | Audit | Member | 01/01/2023 |
